http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H0838183-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3aad7d6029b37483cad3ce16377bfe9d |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H21-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70 |
| filingDate | 1994-07-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_941cb0edb1c7b9f39d7f351f3d078fb2 |
| publicationDate | 1996-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-H0838183-A |
| titleOfInvention | Caldesmon transcription control region |
| abstract | (57) [Summary] [Structure] 5'of the gene encoding Caldesmon A transcriptional regulatory region in the upstream region. [Effect] According to the present invention, a promoter portion located upstream of a gene encoding caldesmon is elucidated, whereby it becomes possible to regulate the expression of caldesmon, and a therapeutic agent for cancer, an anti-atherosclerotic agent and gastrointestinal motility Expressing a large amount of caldesmon useful as an accelerator, It has become possible to use it in gene therapy and to screen for modulators of caldesmon expression. It can also be used for diagnosis of arteriosclerosis. |
| priorityDate | 1994-07-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 131.